lobbying_activities: 1993835

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1993835	cf66dd7b-4193-4c3b-aad9-e8ec94cfa540	Q2	DAIICHI SANKYO, INC.	316731	DAIICHI SANKYO INC	2017	second_quarter	PHA	H.R.2025, Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017 H.R.2430 and S.934, FDA Reauthorization Act of 2017	HOUSE OF REPRESENTATIVES		150000	0	0	2017-07-18T23:39:05.707000-04:00